-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Initiates Coverage On Pacira BioSciences with Equal-Weight Rating, Announces Price Target of $27

Benzinga·12/09/2025 16:04:57
语音播报
Barclays analyst Glen Santangelo initiates coverage on Pacira BioSciences (NASDAQ:PCRX) with a Equal-Weight rating and announces Price Target of $27.